ilomastat has been researched along with tryptophan in 2 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (tryptophan) | Trials (tryptophan) | Recent Studies (post-2010) (tryptophan) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 32,762 | 936 | 7,183 |
| Protein | Taxonomy | ilomastat (IC50) | tryptophan (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 2.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Golub, LM; Kocer, SS; Simon, SR; Walker, SG; Zerler, B | 1 |
2 other study(ies) available for ilomastat and tryptophan
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.
Topics: Animals; Antigens, Bacterial; Bacillus anthracis; Bacterial Toxins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxamic Acids; Indoles; MAP Kinase Kinase 2; MAP Kinase Kinase 6; Metalloproteases; Protein Processing, Post-Translational; Tetracyclines; Tryptophan | 2005 |